U
Build Your Knowledge
Paediatric / developmentalPediatric Urology

Pediatric Neurogenic Bladder

Neurogenic bladder in children (most often from spina bifida) threatens the kidneys when the bladder is high-pressure and poorly compliant — management is driven by urodynamics, centred on clean intermittent catheterisation and anticholinergics to keep pressures low and protect the upper tracts.

Goal
renal preservation
+
Guide
urodynamics
+
Backbone
CIC + anticholinergics
Orientation

The big picture

Children with neurological lesions — most commonly spina bifida (myelomeningocele), also sacral agenesis, spinal cord injury or tethered cord — develop neurogenic lower urinary tract dysfunction. The dangerous pattern is a high-pressure, poorly compliant bladder, often with detrusor–sphincter dyssynergia, which transmits pressure to the upper tracts causing hydronephrosis, reflux, recurrent infection and renal damage. Incontinence is a quality-of-life issue, but renal protection is the priority.

Golden rule

Protect the kidneys by keeping bladder pressures low — let urodynamics guide care, with CIC and anticholinergics as the backbone, escalating to augmentation for a refractory hostile bladder.

Presentation

Symptom sorter

Usually congenital spinal.

Spina bifida (myelomeningocele) — commonestSacral agenesis, tethered cordSpinal cord injuryOther neurological lesions
Work-up

Diagnostic algorithm

Each step answers one question. Tap to expand.

Management

Treatment ladder

Keep intravesical pressures low to protect the kidneys, guided by urodynamics, escalating treatment as needed.

1
Urodynamic characterisation
2
CIC + anticholinergics (lower pressure)
3
Botulinum toxin in selected cases
4
Augmentation ± catheterisable channel if refractory
5
Lifelong upper-tract surveillance
Safety

Complications

Disease complications
  • Renal scarring/impairment from high pressure, reflux, recurrent UTI, incontinence
Treatment complications
  • CIC-related UTIs; augmentation: mucus, stones, metabolic disturbance, perforation risk, rare malignancy
How to prevent
  • Maintain low pressures, surveillance, careful augmentation aftercare
How to manage
  • Escalate therapy to control pressure; manage augmentation complications
Surveillance

Follow-up

What to monitor
  • Upper tracts (ultrasound), renal function, blood pressure
  • Bladder pressures/compliance (urodynamics)
  • Continence and UTIs
Timing
  • Lifelong surveillance with periodic urodynamics and imaging
Success looks like
  • Low-pressure, compliant bladder with protected upper tracts and acceptable continence
Failure looks like
  • Rising pressures, new hydronephrosis/reflux, declining renal function
When to image
  • Routine surveillance and on deterioration
Long-term issues
  • Renal impairment, augmentation-related issues (mucus, stones, metabolic, rare malignancy — needs surveillance)
Recall

Memory hooks

Protect the kidneys — keep pressures low.

Urodynamics guides everything.

CIC + anticholinergics = backbone.

Refractory hostile bladder → augmentation.

Dry but high-pressure is still dangerous.

Exam

Board traps

High storage pressure damages kidneys — the priority is lowering pressure.

Urodynamics is the key investigation.

Augmentation complications (mucus/stones/metabolic/malignancy) need surveillance.

Apply

Clinical cases

Case 1

A child with spina bifida is continent on a timed regimen, but surveillance shows new bilateral hydronephrosis; urodynamics reveals a poorly compliant, high-pressure bladder.

What is the priority and the approach?

Test yourself

Quiz

Back to all modules